Magenta Therapeutics Inc

NASDAQ:MGTA   3:59:55 PM EDT
1.63
-0.14 (-7.91%)
Earnings Announcements

Magenta Therapeutics Reports Quarterly Loss Per Share $0.29

Published: 08/04/2022 13:44 GMT
Magenta Therapeutics Inc (MGTA) - Magenta Therapeutics Reports Second Quarter Financial Results and Recent Program Highlights.
Magenta Therapeutics Inc - Qtrly Loss per Share $0.29.
Magenta Therapeutics Inc - Anticipates Cash, Equivalents Will Be Sufficient to Fund Its Current Operational Plan Into Q2 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.29

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.28

More details on our Analysts Page.